PURE Bioscience CEO Henry Lambert's 2018 pay falls 60% to $428K

PURE Bioscience reports 2018 executive compensation

By ExecPay News

Published: December 20, 2018

PURE Bioscience reported fiscal year 2018 executive compensation information on December 20, 2018.
In 2018, three executives at PURE Bioscience received on average a compensation package of $294K, a 71% decrease compared to previous year.
Average pay of disclosed executives at PURE Bioscience
Henry R. Lambert, Chief Executive Officer, received $428K in total, which decreased by 60% compared to 2017. 70% of Lambert's compensation, or $301K, was in salary. Lambert also received $68K in option awards and $59K in other compensation.
Mark S. Elliott, Vice President Finance, received a compensation package of $236K, which decreased by 3% compared to previous year. 78% of the compensation package, or $185K, was in salary.
Dave J. Pfanzelter, Chairman, earned $218K in 2018, a 87% decrease compared to previous year.
PURE Bioscience's fiscal year ends on July 31.

Related executives

Henry Lambert

PURE Bioscience

Chief Executive Officer

Mark Elliott

PURE Bioscience

Vice President Finance

Dave Pfanzelter

PURE Bioscience

Chairman

You may also like

Source: SEC filing on December 20, 2018.